Mathers Edward T bought TRVI
June 3, 2026 · Form 4 insider transaction
Mathers Edward T bought 35,000 shares of Trevi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$0.00
Total value
N/A
InsiderMathers Edward T
RoleDirector
SecurityNonstatutory Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 4, 2026
Shares owned after35,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on June 3, 2026. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.